NCT00163137View on ClinicalTrials.gov

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

PHASE3CompletedINTERVENTIONAL

Enrollment

540

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Osteoporosis

Interventions

DRUG

lasofoxifene

lasofoxifene 0.25mg

DRUG

raloxifene

raloxifene 60 mg/day

DRUG

Placebo

0 mg/day

Trial Locations (72)

15062

Pfizer Investigational Site, Monessen

Pfizer Investigational Site, Mosessen

15213

Pfizer Investigational Site, Pittsburgh

19610

Pfizer Investigational Site, Wyomissing

19611

Pfizer Investigational Site, West Reading

20817

Pfizer Investigational Site, Bethesda

20886

Pfizer Investigational Site, Gaithersberg

23221

Pfizer Investigational Site, Richmond

23225

Pfizer Investigational Site, Richmond

23229

Pfizer Investigational Site, Richmond

23294

Pfizer Investigational Site, Richmond

23320

Pfizer Investigational Site, Chesapeake

23454

Pfizer Investigational Site, Richmond

Pfizer Investigational Site, Virginia Beach

23502

Pfizer Investigational Site, Norfolk

30308

Pfizer Investigational Site, Atlanta

32605

Pfizer Investigational Site, Gainesville

32607

Pfizer Investigational Site, Gainesville

33037

Pfizer Investigational Site, Key Largo

33143

Pfizer Investigational Site, Miami

33173

Pfizer Investigational Site, Miami

33176

Pfizer Investigational Site, Miami

33407

Pfizer Investigational Site, West Palm Beach

33461

Pfizer Investigational Site, Lake Worth

33607

Pfizer Investigational Site, Tampa

34748

Pfizer Investigational Site, Leesburg

37203

Pfizer Investigational Site, Nashville

37403

Pfizer Investigational Site, Chattanooga

37412

Pfizer Investigational Site, Chattanooga

38018

Pfizer Investigational Site, Cordova

38119

Pfizer Investigational Site, Memphis

38138

Pfizer Investigational Site, Germantown

44195

Pfizer Investigational Site, Cleveland

44314

Pfizer Investigational Site, Akron

48034

Pfizer Investigational Site, Southfield

48201

Pfizer Investigational Site, Detroit

48236

Pfizer Investigational Site, Detroit

50309

Pfizer Investigational Site, Des Moines

55112

Pfizer Investigational Site, Arden Hills

60610

Pfizer Investigational Site, Chicago

67207

Pfizer Investigational Site, Wichita

75230

Pfizer Investigational Site, Dallas

84003

Pfizer Investigational Site, American Fork

84062

Pfizer Investigational Site, Pleasant Grove

84064

Pfizer Investigational Site, Provo

84088

Pfizer Investigational Site, West Jordan

84102

Pfizer Investigational Site, Salt Lake City

87102

Pfizer Investigational Site, Albuquerque

87106

Pfizer Investigational Site, Albuquerque

92037

Pfizer Investigational Site, La Jolla

92064

Pfizer Investigational Site, Poway

92103

Pfizer Investigational Site, San Diego

92123

Pfizer Investigational Site, San Diego

92128

Pfizer Investigational Site, San Diego

94304

Pfizer Investigational Site, Palo Alto

94609

Pfizer Investigational Site, Oakland

94612

Pfizer Investigational Site, Oakland

94705

Pfizer Investigational Site, Berkeley

94706

Pfizer Investigational Site, Albany

97213

Pfizer Investigational Site, Portland

97220

Pfizer Investigational Site, Portland

98104

Pfizer Investigational Site, Seattle

98144

Pfizer Investigational Site, Seattle

92093-0659

Pfizer Investigational Site, La Jolla

19713-2094

Pfizer Investigational Site, Newark

33511-5964

Pfizer Investigational Site, Brandon

33613-3946

Pfizer Investigational Site, Tampa

33614-7118

Pfizer Investigational Site, Tampa

04102

Pfizer Investigational Site, Portland

55415-1226

Pfizer Investigational Site, Minneapolis

44312-1647

Pfizer Investigational Site, Akron

19610-2132

Pfizer Investigational Site, Wyomissing

Sponsors

Lead Sponsor

Ligand Pharmaceuticals

All Listed Sponsors

lead

Ligand Pharmaceuticals

INDUSTRY